ROSEN, LEADING INVESTOR COUNSEL, encourages CVRx, Inc. investors to secure counsel before important deadline in Securities Class Action - CVRX. NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of CVRx, Inc. (NASDAQ: CVRX) between July 25, 2023 and August 6, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 8, 2027. SO WHAT: If you purchased CVRx common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the CVRx class action, go to https://rosenlegal.com/cases/cvrx-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 8, 2027. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, to the lawsuit, defendants made materially false and misleading statements about CVRx's revenue growth, sales practices, regulatory compliance, reimbursement strategy, and sales-force productivity. Specifically, CVRx allegedly generated revenue in part through improper sales practices, including improper marketing of Barostim, kickbacks, and false information provided to government health insurance programs. This conduct allegedly exposed CVRx to liability under the False Claims Act and Anti-Kickback Statute. The complaint also alleges that, contrary to defendants' assurances that the sales force had stabilized, turnover remained elevated and productivity lagged because many sales representatives needed more training and time to become productive. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the CVRx class action, go to https://rosenlegal.com/cases/cvrx-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] www.rosenlegal.com

Gainey McKenna & Egleston announces A class action lawsuit has been filed against CVRx, Inc. (CVRX). NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) - Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Minnesota on behalf of all persons or entities who purchased or otherwise acquired CVRx, Inc. ("CVRx" or the "Company") (NASDAQ: CVRX) securities between July 25, 2023 and August 6, 2026, inclusive (the "Class Period"). The class action charges CVRx and certain of CVRx's top executives with violations of the Securities Exchange Act of 1934. The Complaint alleges that Defendants failed to disclose to investors that: (a) to induce sales growth, CVRx and/or its employees were engaged in illegal and unsustainable sales practices, including improperly marketing Barostim, offering or paying kickbacks, and providing false information to government health insurance programs in violation of the False Claims Act ("FCA") and Anti-Kickback Statute ("AKS"); (b) CVRx's revenues were in part the product of such unlawful conduct and thus unsustainable; (c) the illegal sales and marketing activities increased the risk of criminal and civil liability; and (d) as a result of the foregoing, Defendants' public statements, including the Company's reported revenue, purported growth drivers, compliance with the FCA and AKS, the effectiveness of its patient access and reimbursement strategy, and the effectiveness of CVRx's internal controls over financial reporting were materially false and misleading at all relevant times. Investors who purchased or otherwise acquired shares of CVRx should contact the Firm prior to the January 8, 2027 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected]. Please visit our website at http://www.gme-law.com for more information about the firm.